Suppr超能文献

采用热熔挤出法制备蛇床子素聚合物固体分散体以提高溶解和生物利用度。

Preparation of osthole-polymer solid dispersions by hot-melt extrusion for dissolution and bioavailability enhancement.

机构信息

School of Pharmacy, Nanjing University of Chinese Medicine, 138 Xianlin Street, Nanjing 210046, China.

First College of Clinical Medicine, Nanjing University of Chinese Medicine, 138 Xianlin Street, Nanjing 210046, China.

出版信息

Int J Pharm. 2014 Apr 25;465(1-2):436-43. doi: 10.1016/j.ijpharm.2014.02.040. Epub 2014 Feb 25.

Abstract

The aim of this study was to investigate the potential of solid dispersion to improve the dissolution rate and bioavailability of osthole (Ost), a coumarin derivative with various pharmacological activities but with poor aqueous solubility. In present studies, the Ost solid dispersions were prepared with various polymers including Plasdone S-630, HPMC-E5, Eudragit EPO, and Soluplus by hot-melt extrusion method. In vitro characterizations were performed with differential scanning calorimetry (DSC), X-ray powder diffraction (XPRD), Fourier transform infrared (FT-IR) spectroscopy, and in vitro dissolution studies. In addition, in vivo pharmacokinetic studies of Ost solid dispersions were also conducted in rats after a single oral dose. In comparison to the untreated Ost coarse powder and the physical mixture with polymers, the solid dispersions prepared with Plasdone S-630 or HPMC-E5 (drug/polymer: 1:6) showed a significant enhancement of dissolution rate (∼3-fold higher D30). In addition, such preparations exhibited a significantly decreased Tmax, ∼5-fold higher Cmax and ∼1.4-fold higher AUC when comparing with Ost coarse powder. In conclusion, solid dispersion prepared with appropriate polymer could serve as a promising formulation approach to enhance the dissolution rate and hence oral bioavailability of Ost.

摘要

本研究旨在探讨固体分散体提高蛇床子素(Ost)溶解速率和生物利用度的潜力。Ost 是一种具有多种药理活性但水溶性差的香豆素衍生物。在目前的研究中,通过热熔挤出法将 Ost 固体分散体与各种聚合物(包括 Plasdone S-630、HPMC-E5、Eudragit EPO 和 Soluplus)制备。通过差示扫描量热法(DSC)、X 射线粉末衍射(XPRD)、傅里叶变换红外(FT-IR)光谱和体外溶解研究进行了体外特性研究。此外,还在大鼠单次口服给药后进行了 Ost 固体分散体的体内药代动力学研究。与未处理的 Ost 粗粉和与聚合物的物理混合物相比,用 Plasdone S-630 或 HPMC-E5(药物/聚合物:1:6)制备的固体分散体显示出显著提高的溶解速率(约 3 倍更高的 D30)。此外,与 Ost 粗粉相比,这些制剂表现出显著缩短的 Tmax、约 5 倍更高的 Cmax 和约 1.4 倍更高的 AUC。总之,用适当的聚合物制备的固体分散体可以作为一种有前途的制剂方法,以提高 Ost 的溶解速率和口服生物利用度。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验